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Background.— ALCAPA syndrome is a rare congenital heart disease,
mainly diagnosed during the ﬁrst months of life with a high early
mortality in symptomatic children in the absence of surgery. Adult
form is extremely rare and no recommendation for its management
is available. We undertook this study to analyze initial presentation,
management and long-term outcome of adult patients with ALCAPA.
Methods.— We analyzed retrospectively the data of patients hos-
pitalized for a ﬁrst diagnosis or management of ALCAPA from the
charts of cardiology departments of seven French hospitals.
Results.— Twelve adults (30.2± 21.4 years) were included. Symp-
toms consisted of chest pain (58.3%), supra-ventricular arrhythmia
(42.9%) and heart failure (33.3%). 60% of the ECG were abnormals
(ischemic signs). Echocardiogram showed a mean left ventricular
ejection fraction of 51.5± 12.8%. Mitral regurgitation was present
in 83.3%. Coronary angiography was performed in 83.3% of patients
and always showed ALCAPA. CT-scan, myocardial scintigraphy and
MRI were performed for diagnosis or follow-up (FU) respectively in
45.5%, 41.7% and 27.3% of the cases. Reconstructive surgery was
performed in 11 patients and a mitral valve reconstruction in one
patient. Immediate post-operative complications were: cardiogenic
shock (two patients), non-signiﬁcant narrowing of the transferred
coronary artery ostium that was treated medically (one patient) and
a signiﬁcant stenosis of the pulmonary artery trunk and of the left
coronary artery required surgery (one patient). The only patient
who refused surgery died two years later. Because of pulmonary
hypertension due to a severe ischemic heart disease, one patient
had a coil in the left coronary artery before undergoing a coronary
artery bypass grafting. All operated patients are alive with a FU of
21.3± 21.2 years.
Conclusion.— Diagnosis of ALCAPA in adult patients is very rare and
is conﬁrmed mainly by coronary angiography in presence of atypical
symptoms. Considering its complicated natural course and the good
surgical results, surgery should probably be proposed systematically
even in asymptomatic adults, in case of accidental discovery.
http://dx.doi.org/10.1016/j.acvd.2013.06.038
31
Pressure recording analytical method for
measuring perioperative cardiac output in
pediatric cardiac surgery: A validation study
L. Brisarda,b, M. Videcoqa, M. Fernandeza, L. Berarda,b,
A. De Windta, C. Lejusa,b
a Service d’anesthésie et de réanimation chirurgicale, Hôtel-Dieu,
CHU de Nantes, hôpital Mère-Enfant, place Alexis-Ricordeau,
44093 Nantes, France
b Université de Nantes, faculté des sciences pharmaceutiques,
laboratoire expérimental de simulation en médecine intensive de
l’université de Nantes (LESiMU de Nantes), 9, rue Bias, 44035
Nantes cedex 1, France
Introduction.— Cardiac output (CO) monitoring is important during
pediatric congenital cardiopathy surgery. Doppler transesophageal
echocardiography (TEE) remains the most valuable technique in
perioperative settings. Pressure recording analytical method (PRAM)
uses arterial pressure waveform analysis to continuously measure
CO. This minimally invasive hemodynamic method was assessed
in pediatric intensive care unit but showed controversial results
depending on the range of body surface area (BSA). The relevance
of the method and the pediatric algorithm remains to be assessed
in the perioperative setting.
Objectives.— We assessed agreement of PRAM method and TEE in
measuring perioperative cardiac output during cardiac congenital
surgery in children.
Methods.— Observational, prospective and single center study.
Thirty-six children (median [25th—75th percentiles]): sex ratio
14m/22 f, age 6 years [4 months—15 years]; body surface area
(BSA) 0.74 m2 [0.50—1.11]) were included. Three to seven meas-
ures were simultaneous realized: TEE (aortic diameter followed by
transaortic valve continuous wave-Doppler signal via transgastric
view) and PRAM pediatric algorithm after sternal closure. Lin-
ear correlations, Bland—Altman analysis and percentage of error
(Critchley-Critchley) were performed according to BSA (mix and
BSA < 1.10 m2).
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Results.— One hundred and seventy-three paired measurements
were compared. The mean CO (SD) was 2.5(1.4) l/min with TEE-
CO and 2.3(1.4) l/min with PRAM-CO. The mean bias was 0.2 l/min
with agreements limits —2.4 and 2.8 l/min. Pearson’s correlation
was 0.29 giving a percentage error of 108%. In the group with median
BSA < 1.10 m2 (n = 26, 131 measures), mean CO was 1.9 (0.7) l/min
with TEE-CO and 1.8(0.6) l/min with PRAM-CO. The mean bias was
0.03 l/min with agreements limits —1.06 and 1.13 l/min. Pearson’s
correlation was 0.64 giving a percentage error of 60%.
Conclusions.— Differences between PRAM and TEE were signiﬁcant
at all ages and BSA. These results do not support the use of the
Mostcare® monitor to evaluate CO in the setting of pediatric cardiac
surgery.
http://dx.doi.org/10.1016/j.acvd.2013.06.039
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Introduction.— Heart transplantation is the gold standard therapy
for pediatric end-stage heart failure. Sometimes, the waiting time
for a transplant may be long and a mechanical support is required
despite the use of conventional inotropic drugs. Levosimendan was
proved to be safe and efﬁcient for the treatment of postoperative
low cardiac output syndrome in children.
Aims.— To evaluate the effects of levosimendan in children who are
waiting for heart transplantation.
Patients and methods.— In this single-center retrospective study,
all the pediatric patients (under 18 years) in end-stage heart fail-
ure and with criteria for mechanical support, were included. All
the patients were on the waiting list for heart transplantation. Each
patient received at least one 24-hour infusion of levosimendan until
either heart transplantation or mechanical support initiation. Clini-
cal, biological and echocardiographic data were analyzed according
to the infusions of levosimendan.
Results.— A total of six patients were included over a period of
24 months. The median age was 2 years (2 months—15 years). A
total of 82 infusions were performed. Levosimendan had a positive
effect on enteral feeding. The median BNP level decreased signif-
icantly between day 0 and day 2 (2443 ng/L [1458—3819] versus
1358 ng/L [1025—2534], P = 0.003). While only a trend was noted in
the improvement of the left ventricular ejection fraction (P = 0.054
by the Simpson’s method and P = 0.068 by the Teicholz method), the
subaortic velocity time integral was signiﬁcantly improved between
day 0 and day 8 (12.8 cm/s [10—14.5] versus 15.3 cm/s [14.3—16.9],
P = 0.041). Even if the efﬁcacy of levosimendan seemed to pro-
gressively decrease over the time, the use of this drug allowed an
average lifetime without mechanical support of 177 days. During
this study, no adverse events have been reported, or attributed, to
the use of levosimendan.
Conclusion.— Levosimendan improves hemodynamics in children
in end-stage heart failure, allowing several months of life with-
out mechanical support. This study argues for a systematic use
of levosimendan, in addition to the usual inotropic drugs, in this
context. Levels of BNP, quality of enteral feeding and echocar-
diographic parameters may help to determine the best timing for
infusions.
http://dx.doi.org/10.1016/j.acvd.2013.06.040
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Introduction.— Rejection following cardiac transplant remains
an important cause of morbidity and mortality as well as the
complications of the immunosuppressive therapy. Thus, surveil-
lance of paediatric heart transplant patients is crucial to prevent
these risks or, at least, to allow an early treatment. However, only
few international guidelines have been established concerning the
modalities of this monitoring.
Aims.— To collect and to compare the different practices of paedi-
atric heart transplant surveillance in France.
Patients and methods.— It was a descriptive multicenter study. Each
French paediatric cardiologic centres was contacted by e-mail to
complete an electronic questionnaire.
Results.— Eight centres were involved in the surveillance (includ-
ing seven centres performing paediatric heart transplantation) of
these patients. The average number of followed patients was 16.1
(2—50) per centre. The average number of involved physicians was
3.7 (1—8) including 38% of paediatric cardiologists. Only two cen-
tres had a devoted nurse for this activity. Echocardiography was
considered to be reliable for the early detection of transplant
rejection by 57% of centres. Isovolumic relaxation time was always
collected. Whereas TM measurements were frequently analyzed,
other Doppler measurements were inconsistently reported. Myocar-
dial strain analysis (using speckle tracking method) was almost never
performed (14%). Coronarography was systematically performed in
43%, coronary CT angiogram in 28% and cardiac MRI in 14%. For
patients aged above 1 year, cardiac biopsies were systematically
performed in 86%. The prevention of the transplant coronary artery
disease was conducted using pravastatin in 86%, aspirin in 28% and
clopidogrel in 14%.
Conclusion.— The French practices for the monitoring of paediatric
heart transplant patients are heterogeneous due to the absence of
national guidelines. This study highlights the need for a national
register to establish consensuses for the management of these
patients.
http://dx.doi.org/10.1016/j.acvd.2013.06.041
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